retatrutide patent status Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. π Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Who Makes Retatrutide? Company Behind
Pay in 4 interest-free payments of $6.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Oct 28 - Nov 2














:max_bytes(150000):strip_icc()/Health-GettyImages-1413029048-1570d2105e4840479118ceddf6c46e19.jpg)









